COMMUNIQUÉS West-GlobeNewswire

SafeSpace Global Extends Exclusive BMRT Security Agreement to Houses of Worship and Addiction Treatment Centers
16/10/2026
BMRT’s Base Molecular Resonance ™ Technology Detects the Molecular Signature of a Concealed Firearm from More Than 500 Feet Away and Identifies Drugs Inside Vehicles and Backpacks at a Distance; Expansion Adds More Than [...]
Breast Cancer Awareness Fundraiser with Prairie Cannabis
16/10/2026
Prairie Cannabis Launches Breast Cancer Awareness Fundraiser Supporting Gilda's Club Chicago Throughout October Illinois dispensary partners with nonprofit to provide free cancer support services during Breast Cancer [...]
Moleculin Announces Reverse Stock Split
16/10/2026
HOUSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation [...]
Kexing Biopharm’s Biologics License Application for Long-Acting G-CSF Candidate GB-K02 Accepted for Review
16/10/2026
SAN DIEGO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kexing Biopharm (688136.SH) recently announced that it has received a Notice of Acceptance from China’s National Medical Products Administration (NMPA) for the biologics [...]
Natural Remedies' Bacomind Advances Research on Memory and Cognitive Health With New 600-Participant Study
16/10/2026
BANGALORE, India, Oct. 16, 2026 (GLOBE NEWSWIRE) -- As interest grows in memory, focus and mental sharpness throughout life, new clinical research is exploring the potential of a centuries-old botanical ingredient to [...]
Whole Lotta Dank Debuts Dank Pack Across Alberta, Announces Nationwide Search for Cannabis Partners
16/10/2026
Backed by eight retail locations and over 125,000 deliveries completed, Whole Lotta Dank launches its first cannabis brand, advances 20+ SKUs and seeks long-term partnerships with Canadian producers CALGARY, Alberta, [...]
CHMP recommends approval of Johnson & Johnson’s TALVEY®▼ (talquetamab) plus daratumumab in earlier line treatment of relapsed/refractory multiple myeloma
16/10/2026
If approved, TALVEY ® plus daratumumab will be the only GPRC5D-targeting bispecific antibody combination therapy for relapsed or refractory multiple myeloma as early as second line CHMP recommendation based on Phase 3 [...]
Semax Peptide Introduced by Kylo Peptides for Laboratory Use
16/10/2026
Sheridan, Wyoming, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides has added Semax [ https://kylopeptides.com/product/semax/ ] to its research catalog this week. The compound is a synthetic peptide supplied only for [...]
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease
16/10/2026
BOSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
16/10/2026
Former Dermavant Chief Scientific Officer led development of tapinarof, the first FDA-approved AhR agonist, from mechanistic understanding through approval and commercialization Will lead AT177 through IND-enabling [...]
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
16/10/2026
REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023; mITT population); demonstrated 80% retention of GLP-1 induced weight loss vs 67% for sham 32% of Revita ® participants in [...]
Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types
16/10/2026
Positive opinion supports reducing Libtayo dosing frequency from every three weeks to every six weeks after first 12 weeks of treatment Optional reduction of infusion time for 350 mg dose to 15 to 30 minutes, after a [...]
Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026
16/10/2026
Company to host PDAC focused investor webcast on Friday, October 23, 2026, 7:30 am ET BOSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed [...]
OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director
16/10/2026
OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director Oxford, UK – 16 October 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Dr [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
16/10/2026
PALO ALTO, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes
16/10/2026
Clearance expands twiist's precise insulin delivery and personalized automation to the largest population of people treated with insulin, with time-in-range improvements seen in as little as one day in a pivotal trial 1 [...]
Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy
16/10/2026
Agreement aims to expand the commercial reach of Nanox.AI's Bone Solution in the Italian healthcare market. Collaboration leverages Tecnologie Avanzate's 50 years of experience in the Italian medical technology market, [...]
hear.com Receives 2026 Global Recognition Award for Hearing Care Innovation
16/10/2026
Recognition honors hear.com’s Clinic-in-a-Box® teleaudiology platform and Horizon IX hearing aids for expanding access to personalized, medical-grade hearing care MIAMI, Oct. 16, 2026 (GLOBE NEWSWIRE) -- hear.com, an [...]
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
16/10/2026
BRANFORD, Conn., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule [...]

Pages